We also observed a shorter BCSS in CHEK2 c.1100delC carriers compared to non‐carriers, after accounting for CBC occurrence, age at diagnosis of the first primary BC and tumor characteristics. The gene discussed is CHEK2; the disease is complete blood cell count.